Ahmed, L; Biddle, K; Blundell, A; Koushesh, S; Kiely, P; Sedgwick, P; Sofat, N
(2023)
POS0179 PAIN CHARACTERISTICS IN PEOPLE WITH ACTIVE RHEUMATOID ARTHRITIS RECEIVING ADALIMUMAB AND ABATACEPT: A FEASIBILITY TRIAL OF NOCICEPTIVE, NEUROPATHIC AND PAIN SENSITISATION COMPONENTS.
In: EULAR 2023 European Congress of Rheumatology, Scientific Abstracts, 31 May - 3 June, Milan, Italy.
SGUL Authors: Sofat, Nidhi
|
PDF
Accepted Version
Available under License ["licenses_description_publisher" not defined]. Download (169kB) | Preview |
Official URL: http://dx.doi.org/10.1136/annrheumdis-2023-eular.1...
| Item Type: | Conference or Workshop Item (Poster) | ||||||
|---|---|---|---|---|---|---|---|
| Additional Information: | This article has been accepted for publication in Annals of the Rheumatic Diseases, 2023 following peer review, and the Version of Record can be accessed online at https://doi.org/10.1136/annrheumdis-2023-eular.1955. © Author(s) (or their employer(s)) 2023. | ||||||
| SGUL Research Institute / Research Centre: | Academic Structure > Infection and Immunity Research Institute (INII) | ||||||
| Journal or Publication Title: | Scientific Abstracts | ||||||
| Article Number: | POS0179 | ||||||
| Dates: |
|
||||||
| Publisher License: | Publisher's own licence | ||||||
| URI: | https://openaccess.sgul.ac.uk/id/eprint/116089 | ||||||
| Publisher's version: | https://doi.org/10.1136/annrheumdis-2023-eular.1955 |
Statistics
Item downloaded times since 16 Feb 2024.
Actions (login required)
 |
Edit Item |